Aphios Corporation
Biopharmaceutical company developing enabling technology platforms and enhanced natural therapeutics for certain infectious diseases, cancers and CNS disordersEnhanced therapeutics include small...
www.aphios.com/ View full profile
| |
Axonyx Inc.
Axonyx' mission is to be the leading biopharmaceutical company that develops products and technologies to treat Alzheimer's disease (AD) and other Central Nervous System (CNS) disorders.
Axonyx'...
www.axonyx.com/ View full profile
| |
Bioaccelerate Inc
Bioaccelerate bridges the gap between pharmaceutical innovation and capital markets by acquiring and developing pharmaceutical compounds that have substantial medical and commercial value.
We do...
www.bioaccelerate.com/ View full profile
| |
BASi
BASi is a drug development firm providing contract research services and unique products for the pharmaceutical, biotechnology and medical device industries. The company is a leading manufacturer of...
www.bioanalytical.com/ View full profile
| |
BioCor
Through extensive interactions with the FDA, EMEA, and local European regulatory agencies during IND, end-of-phase II, and pre-NDA meetings we have acquired extensive knowledge in many therapeutic...
www.biocor.com/ View full profile
| |
Biopartners GmbH
Since its inception in 2000, Biopartners has become a leader in the development of biosimilars. It also focuses on the development of innovative, patentable formulations of first-generation...
www.biopartners.ch/ View full profile
| |
BrainCells
BrainCells, INC (BCI) is a leading-edge neurogenesis-based drug discovery and development company targeting novel therapies for depression, mood disorders and other CNS diseases. Neurogenesis is...
www.braincellsinc.com/ View full profile
| |
Cambridge Laboratories
Cambridge Laboratories is a fast growing, dynamic and entrepreneurial pharmaceutical company with extensive product development and commercialisation expertise. Our focus is on specialist...
www.camb-labs.com/ View full profile
| |
Pilot Pharmaceuticals
Pilot Pharmaceuticals develops novel products to treat CNS disorders with unmet medical need and substantial market size. The Company takes candidate drugs from an early discovery stage into clinical...
www.cambp.com/ View full profile
| |
Camurus AB
Turning traditional problems into new opportunities Camurus is a leading provider of drug-delivery systems for peptides, proteins, and insoluble small molecules. Working closely with pharmaceutical...
www.camurus.se/ View full profile
| |
VivaCell Asia Pacific Pte Ltd
VivaCell Biotechnology GmbH is a privately owned contract-based research organisation that provides specialised in vitro and in vivo models. Additional services for clinical trials and marketing...
www.cell-a-vie-biotech.de/ View full profile
| |
Cerebricon Ltd
Cerebricon Ltd. is a provider of high quality and cost effective contract and collaborative preclinical models of CNS disease.
Cerebricon works as an extension of the discovery process and...
www.cerebricon.com/ View full profile
| |
Ceregene, Inc.
Using gene therapy delivery systems, Ceregene's primary focus is the discovery and development of novel genetic therapeutics for the treatment of neurological disorders. Ceregene aims to be the leader...
www.ceregene.com/ View full profile
| |
Clinical Network Services
Clinical Network Services (CNS) is a privately-owned Australian Contract Research Organisation (CRO). Since its foundation in 1998, we continue to be the only Queensland head-quartered CRO offering...
www.clinetserv.com/ View full profile
| |
Comprehensive NeuroScience, Inc
Overview
Neuro-psychopharmacology Experts
Largest central nervous system-focused clinical trials company in U.S.
Multi-therapeutic clinical trial management at 28 research facilities ...
www.cnsclinicaltrials.com/ View full profile
| |
